8:30 AM
8:30 AM
Room #1 8:30am
Room #1 8:30am
WELCOME & ADMINISTRATION
WELCOME & ADMINISTRATION
Elizabeth F. Howell, MD | CME Course Director, University of Utah Department of Psychiatry
KEYNOTE: PHARMACOLOGIC TREATMENTS FOR STIMULANT USE DISORDERS: WHAT DOES THE TREATMENT LITERATURE TELL US?
KEYNOTE: PHARMACOLOGIC TREATMENTS FOR STIMULANT USE DISORDERS: WHAT DOES THE TREATMENT LITERATURE TELL US?
Francis Levin, PhD
10:00 AM
10:00 AM
Room #1 10:00am
Room #1 10:00am
TREATMENT OF ADHD & SUBSTANCE USE DISORDERS
TREATMENT OF ADHD & SUBSTANCE USE DISORDERS
Francis Levin, PhD
Room #2 10:00am
Room #2 10:00am
THE RISE OF FENTANYL IN UTAH: OVERDOSE & ADDICTION
THE RISE OF FENTANYL IN UTAH: OVERDOSE & ADDICTION
Michael Moss, MD
Room #3 10:00am
Room #3 10:00am
HARM REDUCTION IN UTAH & BEYOND
HARM REDUCTION IN UTAH & BEYOND
Mark Bigler, LCSW, PhD;
Room #4 10:00am
Room #4 10:00am
THE RECOVERY RESILIENCE PROGRAM: A NOVEL RELAPSE PREVENTION & ADDICTION RECOVERY INTERVENTION
THE RECOVERY RESILIENCE PROGRAM: A NOVEL RELAPSE PREVENTION & ADDICTION RECOVERY INTERVENTION
Guy du Plessis, MA;
Kevin G. Webb, LCSW11:15 AM
11:15 AM
Room #1 11:15am
Room #1 11:15am
CANCELLED: Sorry - due to unforeseeable circumstances, this session has been cancelled.
CANCELLED: Sorry - due to unforeseeable circumstances, this session has been cancelled.
BENEFITS OF INTEGRATION OF CPS WITH CARE COORDINATION INTO HEALTH CARE SETTINGS
Room #2 11:15am
Room #2 11:15am
BUPRENORPHINE TREATMENT FOR OPIOID USE DISORDER: PAST, PRESENT & FUTURE DIRECTIONS
Adam J. Gordon, MD, MPH
Room #3 11:15am
Room #3 11:15am
STREET TRENDS HITTING OUR COMMUNITIES & CLIENTS
STREET TRENDS HITTING OUR COMMUNITIES & CLIENTS
Joshua Allred, Sgt
Room #4 11:15am
Room #4 11:15am
NICOTINE IN TREATMENT, WHAT’S THE BIG DEAL?
NICOTINE IN TREATMENT, WHAT’S THE BIG DEAL?
Spencer Baker, LCSW
1:15 PM
1:15 PM
Room #1 1:15pm
Room #1 1:15pm
THE ‘METHAMFENTANYL’ WAVE: TARGETED TREATMENTS TOWARDS THE METHAMPHETAMINE PIECE
THE ‘METHAMFENTANYL’ WAVE: TARGETED TREATMENTS TOWARDS THE METHAMPHETAMINE PIECE
Javier Ballester, MD
Room #2 1:15pm
Room #2 1:15pm
EMERGING TRENDS IN THE TREATMENT OF ADDICTIVE DISEASE FOR THE LGBT POPULATION
EMERGING TRENDS IN THE TREATMENT OF ADDICTIVE DISEASE FOR THE LGBT POPULATION
Ejay Jack, MPA, LCSW; Mason S. Turner, MD
Room #3 1:15pm
Room #3 1:15pm
CRAFT – A FAMILY PEER MODEL OF FAMILY SUPPORT FOR ADDICTION RECOVERY
CRAFT – A FAMILY PEER MODEL OF FAMILY SUPPORT FOR ADDICTION RECOVERY
Jennifer B. Slack, BA;Darlene Schultz, BS
Room #4 1:15pm
Room #4 1:15pm
DENTAL APPROACH TO SUD TREATMENT OUTCOME MITIGATION
DENTAL APPROACH TO SUD TREATMENT OUTCOME MITIGATION
Glen R. Hanson, DDS, PhD
2:30 PM
2:30 PM
Room #1 2:30pm
Room #1 2:30pm
HORMONES & SUBSTANCE USE DISORDER – SEX (AND HAVING IT) MATTERS
HORMONES & SUBSTANCE USE DISORDER – SEX (AND HAVING IT) MATTERS
Amy de la Garza, MD
Room#2 2:30pm
Room#2 2:30pm
HEROIN, PILLS, IT ALL KILLS. PROGRAMMING, PARTNERSHIPS & LESSONS LEARNED FROM UTAH NALOXONE
HEROIN, PILLS, IT ALL KILLS. PROGRAMMING, PARTNERSHIPS & LESSONS LEARNED FROM UTAH NALOXONE
Jennifer Plumb, MD, MPH
Room #3 2:30pm
Room #3 2:30pm
TO KRATOM OR NOT TO KRATOM, THAT IS THE QUESTION
TO KRATOM OR NOT TO KRATOM, THAT IS THE QUESTION
Steve Sugden, MD, MPH, FASAM, DipABLM
Room #4 2:30pm
Room #4 2:30pm
OUR FUTURE – OUR PROVIDERS: WHAT’S HAPPENING IN POST-SECONDARY EDUCATION?
OUR FUTURE – OUR PROVIDERS: WHAT’S HAPPENING IN POST-SECONDARY EDUCATION?
Michael Dusoe, PhD, LCSW;Brian Baucom, PhD;Cory Dennis, PhD;Gray Otus, PhD;Zoe Robbins, DNP, PMH-NP;Angelea Panos, PhD, MA, MSW
4:00 PM
4:00 PM
Room #1 4:00pm
Room #1 4:00pm
THE ROLES WE PLAY
THE ROLES WE PLAY
Amy Miner, LCMHC
Room#2 4:00pm
Room#2 4:00pm
HEPATITIS C ELIMINATION & ADDICTION MEDICINE
HEPATITIS C ELIMINATION & ADDICTION MEDICINE
Terry D. Box, MD
Room #3 4:00pm
Room #3 4:00pm
GENETICS OF SUBSTANCE USE DISORDERS
GENETICS OF SUBSTANCE USE DISORDERS
Emily DiBlasi, PhD
Room #4 4:00pm
Room #4 4:00pm
MARIJUANA UPDATES – PREVENTION, POLICY & TREATMENT
MARIJUANA UPDATES – PREVENTION, POLICY & TREATMENT
Clifton R. Uckerman, LCSW